Marty Makary
Showing 1–2 of 2 transcripts.
- All-In Podcast1h 30m
Supercharging a New FDA: Marty Makary on Science, Power & Patients
Marty Makary, Friedberg, Chamath, Jason, Dave
FDA Commissioner Marty McCary has implemented 42 major reforms within his first 10 months to accelerate drug approvals, reduce clinical trial timelines, and restore public trust by ending paternalistic mandates. The agency is reshaping its workforce, shifting research priorities toward environmental and microbiome factors, and challenging China's biotech dominance by streamlining U.S. regulatory infrastructure and adopting AI-driven decision tools. These aggressive changes include converting pivotal trial requirements, eliminating unnecessary animal studies, and reforming food and vaccine policies to lower costs and address chronic disease roots.
- Milken Institute33 min
Conversation with FDA Commissioner Marty Makary & CMS Admin Mehmet Oz | Future of Health Summit 2025
Marty Makary, Mehmet Oz, Esther Krofah
The administration is driving a comprehensive healthcare overhaul that combines aggressive drug pricing strategies like "Most Favored Nation" with FDA reforms designed to slash biosimilar development times by reducing regulatory hurdles and replacing animal testing with computational models. Simultaneously, federal agencies are deploying $3 billion in savings from terminated contracts and AI tools to combat $100 billion in annual fraud while restructuring internal operations to accelerate clinical trial reviews and ensure domestic supply chain security. These initiatives aim to bridge the gap between the U.S.'s $4.9 trillion annual health expenditure and its lagging life expectancy by fostering data interoperability, enforcing new transparency rules, and launching the "Trump Rx" initiative to secure lower-cost, domestically produced medications for consumers.